Lawsuit: Allergan Artificially Inflated Stock Amid Price-Fixing Conspiracy

Drug Industry Daily
A A
A group of investment funds sued Allergan, accusing the company of artificially inflating its stock by conspiring with other manufacturers of generic drugs.

To View This Article:

Login

Subscribe To Drug Industry Daily